Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protectivity and Safety Following Recombinant Hepatitis B Vaccine With Different Source of Hepatitis B Bulk Compared to Hepatitis B (Bio Farma) Vaccine in Indonesian Population

NCT03919578 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT03919578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03919578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protectivity and Safety Following Recombinant Hepatitis B Vaccine With Different Source of Hepatitis B Bulk Compared to Hepatitis B (Bio Farma) Vaccine in Indonesian Population
Lead sponsor
PT Bio Farma
Phase
Phase 2/3
Overall status
Completed
Start date
September 11, 2019
Completion date
February 28, 2020
Enrollment
536 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunogenicity